{"id":14535,"date":"2021-10-13T10:35:47","date_gmt":"2021-10-13T08:35:47","guid":{"rendered":"https:\/\/ggba.swiss\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/"},"modified":"2023-07-04T13:40:23","modified_gmt":"2023-07-04T11:40:23","slug":"chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/","title":{"rendered":"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2"},"content":{"rendered":"\n<p>The newly identified antibody was isolated using lymphocytes from Covid-19 patients enrolled in the ImmunoCoV study being carried out by <a href=\"https:\/\/www.lausanneuniversityhospital.com\/home\" target=\"_blank\" rel=\"noopener\">CHUV<\/a>\u2019s Service of Immunology and Allergy. This antibody is one of the most powerful identified so far against SARS-CoV-2.<\/p>\n<p>In addition to its antiviral properties, the new antibody is designed to have a lasting effect in humans. A typical unaltered antibody provides protection for up to three or four weeks.<\/p>\n<p>But this new one can protect patients for four to six months. That makes it an interesting preventive treatment option for unvaccinated at-risk individuals or for vaccinated individuals who are unable to produce an immune response.\u00a0<\/p>\n<p><strong>A major step forward in the fight against Covid-19<\/strong><\/p>\n<p>CHUV and <a href=\"https:\/\/www.epfl.ch\/en\/\" target=\"_blank\" rel=\"noopener\">EPFL<\/a> now plan to build on these promising results in association with a start-up company which will perform clinical development and production of the antibody-containing drug, through cooperation and intellectual property agreements. Clinical trials of the drug should begin in late 2022.<\/p>\n<p>The discovery of this new antibody marks a major step forward in the fight against Covid-19. It opens the door to improved treatments for severe forms of the disease and to enhanced prophylactic measures, especially for patients with weakened immune systems.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CHUV and EPFL have discovered a highly potent monoclonal antibody targeting the SARS-COV-2 Spike protein. This antibody neutralizes all variants of the virus, including the delta variant.<\/p>\n","protected":false},"author":3,"featured_media":14536,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[884],"class_list":["post-14535","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-covid-19"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CHUV and EPFL discover a highly potent antibody against SARS-CoV-2 - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2 - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"CHUV and EPFL have discovered a highly potent monoclonal antibody targeting the SARS-COV-2 Spike protein. This antibody neutralizes all variants of the virus, including the delta variant.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-13T08:35:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:40:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2\",\"datePublished\":\"2021-10-13T08:35:47+00:00\",\"dateModified\":\"2023-07-04T11:40:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/\"},\"wordCount\":210,\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg\",\"keywords\":[\"Covid-19\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/\",\"name\":\"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2 - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg\",\"datePublished\":\"2021-10-13T08:35:47+00:00\",\"dateModified\":\"2023-07-04T11:40:23+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2 - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/","og_locale":"en_US","og_type":"article","og_title":"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2 - Greater Geneva Bern area","og_description":"CHUV and EPFL have discovered a highly potent monoclonal antibody targeting the SARS-COV-2 Spike protein. This antibody neutralizes all variants of the virus, including the delta variant.","og_url":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2021-10-13T08:35:47+00:00","article_modified_time":"2023-07-04T11:40:23+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mathieu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#article","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2","datePublished":"2021-10-13T08:35:47+00:00","dateModified":"2023-07-04T11:40:23+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/"},"wordCount":210,"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg","keywords":["Covid-19"],"articleSection":["Life sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/","url":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/","name":"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2 - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#primaryimage"},"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg","datePublished":"2021-10-13T08:35:47+00:00","dateModified":"2023-07-04T11:40:23+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/iStock-EPFL-CHUV-630x380-1-3.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/staging.ggba.swiss\/en\/chuv-and-epfl-discover-a-highly-potent-antibody-against-sars-cov-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"CHUV and EPFL discover a highly potent antibody against SARS-CoV-2"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/en\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=14535"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14535\/revisions"}],"predecessor-version":[{"id":17009,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14535\/revisions\/17009"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/14536"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=14535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=14535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=14535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}